Skip to Main Content

Paper Details

Molecular Profiling and Targeted Therapies in Gliomas.
1
2023
BRAFV600E, Gliomas, H3K27M, IDH, IDH1/2, dabrafenib, diffuse midline gliomas, gliomas, patients, trametinib, tumor, vorasidenib
Author NameAffiliation
Patrick Y WenCenter For Neuro-Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital and Harvard Medical School
  • 1 - 1

Datasets

Release 1.2